Sign In
Buy KVUE
$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
Trump links autism to Tylenol ingredient use during pregnancy — here's what to know
09:12am, Wednesday, 24'th Sep 2025
The Trump administration on Monday drew an unproven link between autism and pregnant women's use of acetaminophen, the active ingredient in one of the world's most common over-the-counter pain relieve
Tylenol maker Kenvue rebounds after Trump spreads unproven claims
07:01pm, Tuesday, 23'rd Sep 2025
Shares of Tylenol maker Kenvue bounced back sharply at the opening bell Tuesday, a day after President Donald Trump promoted unproven and, in some cases, discredited ties between Tylenol, vaccines, an
Kenvue Stock Recoups Losses After Trump Links Tylenol to Autism
03:20pm, Tuesday, 23'rd Sep 2025
Kenvue stock is rebounding. It may be a largely a case of things-could've-been- worse.
How Trump is spreading unproven information about Tylenol, autism, and vaccines
01:51pm, Tuesday, 23'rd Sep 2025
President Donald Trump on Monday used the platform of the presidency to promote unproven and in some cases discredited ties between Tylenol, vaccines and autism as his administration announced a wide-
Pharmaceutical Stock Bounces Off Record Lows
10:54am, Tuesday, 23'rd Sep 2025
Kenvue Inc (NYSE:KVUE) stock is up 3.9% to trade at $17.62 at last check, erasing some of yesterday's losses that followed the Trump administration connection between the use of acetaminophen -- the
Tylenol: Kenvue's Sobering Reality
10:43am, Tuesday, 23'rd Sep 2025
I'm initiating Kenvue Inc. with a Buy after a sharp selloff following President Donald Trump's remarks on Monday linking Tylenol with autism. KVUE's profitability, with gross margins above 58% and EBI
QUOTE BOX Global reaction to Trump's unproven claim about Tylenol's link to autism
10:28am, Tuesday, 23'rd Sep 2025
U.S. President Donald Trump on Monday linked autism to childhood vaccines and the use of popular pain medication Tylenol by women when pregnant, elevating claims not backed by scientific evidence to t
Shares of Kenvue rebound today after Trump admin ties use of acetaminophen to autism
10:07am, Tuesday, 23'rd Sep 2025
CNBC's Angelica Peebles joins 'Squawk on the Street' with the latest news on the Trump administration's announcement linking acetaminophen taken during pregnancy to autism.
KVUE Rebounds Against Trump Admin, BA International Boost, AZO Earnings Miss
10:00am, Tuesday, 23'rd Sep 2025
Kenvue (KVUE) rallied Tuesday morning despite the Trump administration linking Tylenol to autism. Diane King Hall notes that analyst commentary may have helped the stock's upward trajectory.
Tylenol Maker Kenvue Shares Rebound After Trump Links Drug To Autism
09:51am, Tuesday, 23'rd Sep 2025
23%. That's the estimated percentage of adults in the U.S.—roughly 52 million people—who consume a medicine with acetaminophen each week, according to the nonprofit Consumer Healthcare Products As
Tylenol Maker Kenvue Rebounds In Premarket After Trump Links Drug To Autism
09:35am, Tuesday, 23'rd Sep 2025
23%. That's the estimated percentage of adults in the U.S.—roughly 52 million people—who consume a medicine with acetaminophen each week, according to the nonprofit Consumer Healthcare Products As
Trump admin draws unproven link between autism and Tylenol ingredient use during pregnancy
09:33am, Tuesday, 23'rd Sep 2025
The Trump administration on Monday drew an unproven link between autism and pregnant women's use of acetaminophen, the active ingredient in one of the world's most common over-the-counter pain relieve
Kenvue bounces after Trump's Tylenol remarks spark sell-off
09:02am, Tuesday, 23'rd Sep 2025
After a bruising session on Monday, Kenvue Inc (NYSE:KVUE) shares staged a 6% rebound in premarket trade on Tuesday, clawing back much of the previous day's 7.5% drop. The rally came after President
Kenvue Stock Bounces Back After Trump Links Tylenol to Autism. Here's Why.
07:51am, Tuesday, 23'rd Sep 2025
“Independent, sound science clearly shows that taking acetaminophen does not cause autism,” a Kenvue spokesperson told Barron's.
Wall Street Breakfast Podcast: Kenvue In Focus
06:33am, Tuesday, 23'rd Sep 2025
Kenvue (KVUE) rebounds 6% premarket after sharp drop, following FDA warning on acetaminophen use during pregnancy and company defense of Tylenol's safety. Boeing (BA) secures Uzbekistan Airways' large
